MAPT and supranuclear palsy, progressive, 1: By adapting the ultrasensitive tau seed amplification assay (4R RT-QuIC), a study analyzed CSF from living people and postmortem samples diagnosed as PSP and CBD, and identified three 4R tau seeds associated with diseases [139], which needs further validation.